Status:

RECRUITING

The Beneficial Effects of Naps on Motor Learning

Lead Sponsor:

National Institute of Neurological Disorders and Stroke (NINDS)

Conditions:

Stroke

Eligibility:

All Genders

18-80 years

Brief Summary

Background: Memory consolidation is the process by which memories become stable, long-term representations in the brain. Consolidation of a motor skill is dependent upon sleep. Some research shows th...

Detailed Description

Study Description: We will investigate the within-individual contribution of wakeful and sleep neural replay to motor skill consolidation in three groups: (a) young healthy subjects, (b) older health...

Eligibility Criteria

Inclusion

  • HEALTHY VOLUNTEERS:
  • INCLUSION CRITERIA:
  • Age 18-35 (Arm 1) or 50-80 (Arms 2).
  • English speaking.
  • Clear right-hand dominance (\>74 on Edinburgh Handedness Inventory).
  • Normal neurological examination as determined by the screening clinician.
  • EXCLUSION CRITERIA:
  • HCPS affiliated NIH staff (i.e. - staff from our section).
  • Current pregnancy.
  • Contraindications for MRI or MEG.
  • Use of sleep medications within 24 hours of Experimental Session participation.
  • Severe or progressive neurological, psychological or medical condition as determined by the screening clinician.
  • STROKE PATIENTS:
  • INCLUSION CRITERIA:
  • Age 18 or older
  • Willing and able to provide consent
  • Experienced a stroke 6 months ago or more that affected at least one of the upper extremities at time of stroke diagnosis
  • Ability to perform the study task as assessed during physical examination
  • English-speaking
  • EXCLUSION CRITERIA:
  • HCPS-affiliated NIH staff (i.e. - staff from our section).
  • Current pregnancy
  • History of large stroke lesions in brainstem or cerebellum as determined by screening clinician
  • Severe or progressive neurological disorder other than stroke (e.g., Parkinson s disease or multiple sclerosis) as determined by the screening clinician
  • Uncontrolled heart, lung, kidney, gastrointestinal, metabolic, psychiatric, sleep, or endocrine disorders as determined by the screening clinician
  • Contraindications for MRI or MEG.

Exclusion

    Key Trial Info

    Start Date :

    March 4 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 1 2026

    Estimated Enrollment :

    199 Patients enrolled

    Trial Details

    Trial ID

    NCT04312126

    Start Date

    March 4 2021

    End Date

    August 1 2026

    Last Update

    August 20 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892